Regulation of CS1 fibronectin expression and function by IL-1 in endothelial cells

Cellular Immunology

Volumn 200, Issue 1, 2000, Pages 1-7

  Boyle, David L ^a   Shi, Yan ^a   Gay, Steffen ^b   Firestein, Gary S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cell adhesion; Cytokines; Endothelial cell; Rheumatoid arthritis

Indexed keywords

ANTIBODY; FIBRONECTIN; MESSENGER RNA; RECOMBINANT INTERLEUKIN 1; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS;

EID: 0034712281     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1006/cimm.2000.1610     Document Type: Article

References (34)

1. Cronstein B. N., Weissmann G. The adhesion molecules of inflammation. Arthritis Rheum. 36:1993;147-157.
2. Szekanecz Z., Szegedi G., Koch A. E. Cellular adhesion molecules in rheumatoid arthritis: Regulation by cytokines and possible clinical importance. J. Invest. Med. 44:1996;124-135.
3. Elices M. J., Tsai V., Strahl D., Goel A., Tollefson V., Arrhenius T., Wayner E., Gaeta F., Fikes J., Firestein G. S. Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature. J. Clin. Invest. 93:1994;405-416.
4. Laffon A., Garcia-Vicuna R., Humbria A., Postigo A. A., Corbi A. L., de Landazuri M. O., Sanchez-Madrid F. Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis. J. Clin. Invest. 88:1992;546-552.
5. Postigo A. A., Garcia-Vicuna R., Diaz-Gonzalez F., Arroyo A. G., de Landazuri M. O., Chi-Rosso G., Lobb R. R., Laffon A., Sanchez-Madrid F. Increased binding of synovial T lymphocytes from rheumatoid arthritis to endothelial-leukocyte adhesion molecule-1 (ELAM-1) and vascular cell adhesion molecule-1 (VCAM-1). J. Clin. Invest. 89:1992;1445-1452.
6. Elices M. J., Osborn L., Takada Y., Crouse C., Lubowskyj S., Hemler M. E., Lobb R. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell. 60:1990;577-584.
7. Schwarz B. R., Wayner E. A., Carlos T. M., Ochs H. D., Harlan J. M. Identification of surface proteins mediating adherence of CD11/CD18-deficient lymphoblastoid cells to cultured human endothelium. J. Clin. Invest. 85:1990;2019-2022.
8. Wayner E. A., Garcia-Pardo A., Humphries M. J., McDonald J. A., Carter W. G. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J. Cell Biol. 109:1989;1321-1330.
9. Muller-Ladner U., Elices M., Kriegsmann J. B., Strahl D., Gay R. E., Firestein G. S., Gay S. Expression of the alternatively spliced CS-1 fibronectin isoform and its counter-receptor VLA-4 in rheumatoid arthritis synovium. J. Rheumatol. 24:1997;1873-1880.
10. Vanderslice P., Ren K., Revelle J. K., Kim D. C., ScotT D., Bjercke R. J., Yeh E. T., Beck P. J., Kogan T. P. Cyclic hexapeptide is a potent antagonist of alpha 4 integrins. J. Immunol. 158:1997;1710-1718.
11. Firestein G. S. Starving the synovium: Angiogenesis and inflammation in rheumatoid arthritis. J. Clin. Invest. 103:1999;3-4.
12. Firestein G. S., Alvaro-Gracia J. M., Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J. Immunol. 144:1990;3347-3353.
13. Carsons S. E. The structure and function of fibronectin. Carson S. E. Fibronectin in Health and Disease. 1989;1-21 CRC Press, Boca Raton.
14. Hynes R. O. Fibronectins. 1990;Springer-Verlag, New York.
15. Tamkun J. W., Schwarzbauer J. E., Hynes R. O. A single rat fibronectin gene generates three different mRNAs by alternative splicing of a complex exon. Proc. Natl. Acad. Sci. USA. 81:1984;5140-5144.
16. Hershberger R. P., Culp L. A. Cell-type-specific expression of alternatively spliced human fibronectin IIICS mRNAs. Mol. Cell. Biol. 10:1990;662-671.
17. Humphries M. J., Akiyama S. K., Komoriya A., Olden K., Yamada K. M. Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesion. J. Cell Biol. 103:1986;2637-2647.
18. Guan J.-L., Hynes R. O. Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor α4β1. Cell. 60:1990;53-61.
19. Ferguson T. A., Mizutani H., Kupper T. S. Two integrin-binding peptides abrogate T cell-mediated immune responses in vivo. Proc. Natl. Acad. Sci. USA. 88:1991;8072-8076.
20. Issekutz T. B., Issekutz A. C. T lymphocyte migration to arthritic joints and dermal inflammation in the rat: Differing migration patterns and the involvement of VLA-4. Clin. Immunol. Immunopathol. 61:1991;436-447.
21. Seiffge D. Protective effects of monoclonal antibody to VLA-4 on leukocyte adhesion and course of disease in adjuvant arthritis in rats. J. Rheumatol. 23:1996;2086-2091.
22. Molossi S., Elices M., Arrhenius T., Diaz R., Coulber C., Rabinovitch M. Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts. J. Clin. Invest. 95:1995;2601-2610.
23. Coito A. J., Korom S., Graser E., Volk H. D., Van De Water L., Kupiec-Weglinski J. W. Blockade of very late antigen-4 integrin binding to fibronectin in allograft recipients: I. Treatment with connecting segment-1 peptides prevents acute rejection by suppressing intragraft mononuclear cell accumulation, endothelial activation, and cytokine expression. Transplantation. 65:1998;699-706.
24. Korom S., Hancock W. W., Coito A. J., Kupiec-Weglinski J. W. Blockade of very late antigen-4 integrin binding to fibronectin in allograft recipients. II. Treatment with connecting segment-1 peptides prevents chronic rejection by attenuating arteriosclerotic development and suppressing intragraft T cell and macrophage activation. Transplantation. 65:1998;854-859.
25. Wahl S. M., Allen J. B., Hines K. L., Imamichi T., Wahl A. M., Furcht L. T., McCarthy J. B. Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment. J. Clin. Invest. 94:1994;655-662.
26. Craddock C. F., Nakamoto B., Elices M., Papayannopoulou T. The role of CS1 moiety of fibronectin in VLA mediated haemopoietic progenitor trafficking. Br. J. Haematol. 97:1997;15-21.
27. Kocher O., Kennedy S. P., Madri J. A. Alternative splicing of endothelial cell fibronectin mRNA in the IIICS region. Am. J. Pathol. 137:1990;1509-1524.
28. Wang A., Cohen D. S., Palmer E., Sheppard D. Polarized regulation of fibronectin secretion and alternative splicing by transforming growth factor β J. Biol. Chem. 266:1991;15598-15601.
29. McKay N. G., Hunter D. J., Haites N. E., Power D. A. Regulation of alternative splicing of the fibronectin IIICS domain by cytokines. Biochem. Biophys. Res. Commun. 199:1994;1005-1011.
30. Masumoto A., Hemler M. E. Multiple activation states of VLA-4. Mechanistic differences between adhesion to CS1/fibronectin and to vascular cell adhesion molecule-1. J. Biol. Chem. 268:1993;228-234.
31. Makarem R., Newham P., Askari J. A., Green L. J., Clemens J., Edwards M., Humphries M. J., Mould A. P. Competitive binding of vascular cell adhesion molecule-1 and the HepII/IIICS domain of fibronectin to the integrin alpha4 beta1. J. Biol. Chem. 269:1994;4005-4011.
32. Pulido R., Elices M. J., Campanero M. R., Osborn L., Schiffer S., Garcia-Pardo A., Lobb R., Hemler M. E., Sanchez-Madrid F. Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. J. Biol. Chem. 266:1991;10241-10245.
33. Munoz M., Serrador J., Nieto M., Luque A., Sanchez-Madrid F., Teixido J. A novel region of the alpha4 integrin subunit with a modulatory role in VLA-4-mediated cell adhesion to fibronectin. Biochem. J. 327:1997;727-733.
34. Morales-Ducret J., Wayner E., Elices M. J., Alvaro-Gracia J. M., Zvaifler N. J., Firestein G. S. α4/β1 integrin (VLA-4) ligands in arthritis: Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J. Immunol. 149:1992;1424-1431.